arrow
P

Przepiorka, Donna

us food & drug administration (fda)
H指数:0
被引数:50

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy
2022-02-2121
OA
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

FDA批准摘要: Ivosidenib用于异柠檬酸脱氢酶-1突变的复发或难治性急性髓系白血病

2019-06-03113
OAAI
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
2019-05-01227
OAAI
FDA Approval: Blinatumomab

FDA批准: Blinatumomab

2015-09-14273
OAAI
FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma
2015-03-31138
OAAI